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Abstract
Background: Primary hepatic angiosarcoma is a non-epithelial malignancy derived from sinusoidal endothelial cells,
accounting for approximately 1.8% of primary hepatic malignancies. Diagnosis of primary hepatic angiosarcoma is
complicated by difficulties in the qualitative radiological assessment of these tumors. Prognosis is very poor due to
local recurrence and distant metastasis after liver resection or liver transplantation (LT).
Case presentation: This case report describes two patients with primary hepatic angiosarcoma who were diagnosed
by histopathological examination of the explanted liver after LT. One patient had undergone living donor LT, and the
other had undergone deceased donor LT. Neither showed evidence of malignancy on the pre-operative imaging tests.
Conclusions: Hepatic angiosarcoma has a very high relapse rate after LT. Pre-transplant liver biopsy may be necessary
to distinguish diffuse hepatic angiosarcoma from tumors of other origin in patients with cryptogenic liver failure.
Keywords: Diffuse hepatic angiosarcoma, Living donor liver transplantation, Deceased donor liver transplantation,
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Background
Cryptogenic liver failure remains an important cause of
liver transplantation (LT) despite technical advances in
imaging modalities and laboratory examinations [1, 2].
Hepatic angiosarcoma is a rare and aggressive malig-
nancy with a poor prognosis and is difficult to diagnose
in the absence of exposure to environmental carcino-
gens, such as thorotrast, polyvinyl chloride monomer,
and arsenic [3, 4]. Diffuse type hepatic angiosarcoma is
extremely rare and is very difficult to diagnose pre-
operatively. Because these patients have a very poor
prognosis after LT, owing to high rates of local recur-
rence and distant metastasis, LT is contraindicated in
patients with these tumors [5]. As liver biopsy for pa-
tients with liver failure is risky, hepatic angiosarcoma is
usually diagnosed by post-operative histopathological
examination. This report describes two patients who
underwent LT for cryptogenic liver failure and were
found to have hepatic angiosarcoma on pathological
examination of the explanted livers.
Case presentation
Patient 1
A 59-year-old female with esophageal varices and minor
ascites visited a local hospital for abdominal pain. Blood
tests revealed thrombocytopenia and mild liver dysfunc-
tion. She was negative for markers of viral hepatitis and
autoimmunity, and her hepatic venous pressure was not
elevated. Idiopathic portal hypertension was suspected.
Ligation of endoscopic varices resulted in worsening of
liver function. She was transferred to our hospital for liv-
ing donor liver transplantation (LDLT). At admission,
she was classified as Child-Pugh grade C with 11 points
and her model for end-stage liver disease (MELD) score
was 17. Abdominal contrast enhanced computed tomog-
raphy (CT) revealed several small, low-intensity nodules
in the liver but showed no definite tumors (Fig. 1a). Her
39-year-old son donated the left lobe of his liver for
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LDLT. Laparotomy revealed a soft and flabby liver, an
enlarged spleen, and minor ascites. The post-LDLT
course of the recipient was uneventful, and she was
discharged from hospital 16 days after surgery. Histo-
pathology of the explanted liver revealed spindle-
shaped cells with nuclear variant and sinusoid expan-
sion. The tumor was diffusely spread in the explanted
liver and occupied about 20–30% of the liver (Fig. 2a,
b). Immunohistochemically, these cells were positive
for CD31, CD34, HHV-8, SMA, and ERG (Fig. 3a),
resulting in a diagnosis of diffuse hepatic angiosar-
coma. Contrast enhanced CT 9 months after LDLT
showed recurrence of angiosarcoma in the trans-
planted liver. Despite systemic chemotherapy, she died
27 months after LDLT.
Patient 2
A 43-year-old male visited a local hospital for abnor-
mal liver function. Because his liver function was
worsening, he was admitted to our hospital. Enhanced
CT revealed hepatosplenomegaly. The contrast effect
of the liver was blocky. No tumor in the liver was
observed (Fig. 1b). He was classified as Child-Pugh
grade C with 12 points, and his MELD score was 36.
He underwent deceased donor liver transplantation
(DDLT) from a brain dead 18-year-old male. His
post-DDLT course was uneventful, and he was
discharged from the hospital 22 days after surgery.
Histopathology of the explanted liver revealed dilated
sinusoid lined by atypical spindle-shaped cells with
diffuse polymorphic and hyperchromatic nuclei.
Immunohistochemically, these cells were positive for
CD31 (Fig. 3b), but negative for CD34 and ERG.
These features indicated diffuse hepatic angiosarcoma.
His tumor recurred immediately after transplantation,
and he died 6 months after DDLT.
Discussion
About 2–3% of soft-tissue sarcomas in adults are
angiosarcomas. Primary hepatic angiosarcoma is a
rare malignancy, accounting for about 1.8% of all pri-
mary hepatic tumors and fewer than 5% of angiosar-
comas [6, 7]. The peak age at onset is 60–70 years
old, with a male-to-female predominance as high as
Fig. 1 a Case 1. b Case 2. Computed tomography (CT) imaging revealed hepatosplenomegaly and the contrast effect of the liver was blocky.
These findings may be an indicator of angiosarcoma
Fig. 2 Recipient’s liver of case 1 a at laparotomy, and b macroscopic pathology showed white spongy structure in the explanted liver
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3:1. Although the main cause of hepatic angiosarcoma
is exposure to environmental carcinogens, causes re-
main unknown in many patients [3, 4, 8]. Its symp-
toms are nonspecific and can include abdominal pain,
weakness, fatigue, weight loss, anorexia, and abdom-
inal enlargement. There is no relationship between
hepatic angiosarcoma and portal hypertension. In the
patient 1, however, the patient presented with esopha-
geal varices. There are some case reports of hepatic
angiosarcoma had associated with idiopathic portal
hypertension, but the frequency is not high. The rela-
tionship is not clear. Diffuse hepatic angiosarcomas
are especially difficult to diagnose by imaging modal-
ities, although a blocky contrast effect of the whole
liver in enhanced CT may be an indicator. These
findings may suggest angiosarcomas, but they look
very much alike hyperplastic nodules in liver cirrhosis.
FDG-PET in one patient showed extensive diffuse ab-
dominal accumulation throughout the whole liver,
suggesting a malignant tumor [9, 10]. Histopatho-
logically, these tumors are characterized by dilated si-
nusoids lined by hypertrophied endothelial cells with
atypical and hyperchromatic nuclei. Immunohisto-
chemistry has shown that these tumors are usually
positive stains for endothelial markers, such as HHV-
8, CD31, CD34, and ERG [10, 11]. About 7.7% of pri-
mary hepatic angiosarcomas are diffuse hepatic angio-
sarcomas [4]. Of 59,462 patients diagnosed with liver
tumors from 1987 through 2003 in the UNOS data-
base, seven (0.0117%) with diffuse hepatic angiosar-
coma underwent liver transplantation and were
pathologically diagnosed post-operatively. Their mean
duration of survival after transplantation was 262 ±
146 days [12]. Owing to their poor prognosis and high
recurrence rate, LT is contraindicated for patients with
hepatic angiosarcomas, especially those with diffuse
hepatic angiosarcomas [7]. In both cases, addition of
chemotherapy such as IL-2 might be necessary after the
established diagnoses.
Conclusions
Liver biopsies are difficult to obtain from patients with
cryptogenic liver failure. Nevertheless, pre-transplant
liver biopsy may be necessary to distinguish diffuse hep-
atic angiosarcomas from tumors of other origin in pa-
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